Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...